Learning objectives: To recognize challenges in the development of clinical trials for frontline diffuse large B-cell lymphoma.

To appreciate new therapeutic strategies for improving outcomes in DLBCL.

Session date: 
10/12/2021 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Christopher Flowers, MD